Posts Tagged ‘ CO2 ’

FemiLift (FDA) – Dr. Madeline Tarrillion

U.S. Food and Drug Administration (FDA) Clearance of CO2 lasers: Genitourinary syndrome of menopause (GSM), previously known as vulvovaginal atrophy (VVA), is a condition affecting postmenopausal women, which usually includes vaginal dryness, burning, itching, irritation, urinary incontinence, dysuria (pain with urination) and dyspareunia (pain with sexual activity). Standard therapies include vaginal moisturizers, low dose topical… Read More »


Our Office

Lloyd Dermatology Center

8060 Market Street
Youngstown, OH 44512

Phone: 330.758.9189Fax: 330.758.4487

Office Hours:

Monday – Friday
8:00 a.m. – 5:00 p.m.